Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Accounts Payables (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Accounts Payables data on record, last reported at $553.7 million in Q4 2025.

  • For Q4 2025, Accounts Payables rose 26.42% year-over-year to $553.7 million; the TTM value through Dec 2025 reached $553.7 million, up 26.42%, while the annual FY2025 figure was $553.7 million, 26.42% up from the prior year.
  • Accounts Payables reached $553.7 million in Q4 2025 per AHCO's latest filing, up from $521.7 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $553.7 million in Q4 2025 and bottomed at $28.1 million in Q1 2021.
  • Average Accounts Payables over 5 years is $352.6 million, with a median of $350.7 million recorded in 2021.
  • Peak YoY movement for Accounts Payables: tumbled 79.32% in 2021, then surged 1022.94% in 2022.
  • A 5-year view of Accounts Payables shows it stood at $358.4 million in 2021, then fell by 5.83% to $337.5 million in 2022, then rose by 16.15% to $392.0 million in 2023, then grew by 11.73% to $438.0 million in 2024, then increased by 26.42% to $553.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $553.7 million in Q4 2025, $521.7 million in Q3 2025, and $421.2 million in Q1 2025.